Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological Malignancies

Recruiting N/A Interventional Study
Tumor Recurrence Malignant Epithelial Neoplasm of Vulva Malignant Epithelial Tumor of Ovary Malignant Epithelial Neoplasm
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Female
Study type
Interventional
Purpose
Treatment
Participants needed
55 (estimated)
Sponsor
CNAO National Center of Oncological Hadrontherapy · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The study aims to obtain a local control rate in patients with lateral pelvic relapses of gynecologycal cancers previously irradiated. High LET (Linear Energy Transfer) particles as carbon ions can guarantee a biologic advantage compared to photons in radioresistant neoplasms, given to their higher biological efficacy (RBE).

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients ≥ 18 years of age * Karnofsky Index ≥ 70 * Histological or radiological diagnosis of pelvic and groin recurrence * Contraindications for radical surgery * No other distant progression or stable disease (SD) of known secondarisms (≥6 months) * Previous radiation therap…
Contacts

Amelia Barcellini, MD

390382075501

amelia.barcellini@cnao.it

CONTACT

Cristina Bono, MSc

390382075613

cristina.bono@cnao.it

CONTACT